Syros Pharmaceuticals, Inc.【SYRS】業績推移・財務諸表

（単位：千ドル）	2Q16	3Q16	4Q16	1Q17	2Q17	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	4Q20	1Q21	2Q21	3Q21	4Q21	1Q22	2Q22	3Q22	4Q22	1Q23	2Q23	3Q23	4Q23	1Q24	2Q24	3Q24
現金同等物	50,116	93,494	58,588	47,999	79,531	42,149	32,205	94,817	114,676	44,452	50,814	26,143	105,754	37,378	44,817	119,959	111,760	96,219	177,070	225,228	164,001	118,506	95,388	72,661	62,150	174,618	170,553	107,851	118,528	115,305	141,645	85,642	81,083	60,394
有価証券	-	-	25,005	22,495	11,990	39,799	39,844	27,407	9,980	69,707	49,793	53,737	19,978	74,774	49,975	5,003	-	-	-	-	21,114	30,164	38,067	40,686	27,220	72,949	34,837	61,038	28,540	-	-	24,781	-	-
現金 + 有価証券	50,116	93,494	83,593	70,494	91,521	81,948	72,049	122,224	124,656	114,159	100,607	79,880	125,732	112,152	94,792	124,962	111,760	96,219	177,070	225,228	185,115	148,670	133,455	113,347	89,370	247,567	205,390	168,889	147,068	115,305	141,645	110,423	81,083	60,394
売掛金	-	-	867	551	-	-	-	-	-	-	-	-	-	-	-	-	2	2	7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
流動資産合計	52,153	94,881	85,508	72,505	93,190	83,167	73,159	123,370	126,951	115,544	101,734	77,763	124,368	111,020	114,513	125,695	112,451	98,563	178,557	226,677	186,207	153,271	136,585	116,477	91,945	252,305	211,392	173,644	152,630	122,515	144,980	112,202	84,921	63,931
有形固定資産	4,773	4,603	4,850	4,546	4,508	4,127	3,938	3,565	3,275	3,908	3,861	3,897	5,443	11,147	15,210	15,756	15,361	15,020	14,213	13,927	13,784	13,458	12,844	12,554	11,994	12,062	11,353	10,950	10,299	7,614	7,298	6,964	6,633	6,308
投資有価証券	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,264	21,117	13,038	2,638	-	-	-	-	-	-	-	-	-	-
固定資産合計	8,793	5,529	5,815	5,518	5,841	5,510	5,329	4,730	4,428	5,090	5,032	10,665	27,459	32,811	35,465	35,705	35,365	34,772	34,693	33,950	47,527	54,772	46,350	35,604	34,289	32,420	33,094	31,679	28,352	25,280	23,194	22,526	21,801	21,064
総資産	60,946	100,410	91,323	78,023	99,031	88,677	78,488	128,100	131,379	120,634	106,766	88,428	151,827	143,831	149,978	161,400	147,816	133,335	213,250	260,627	233,734	208,043	182,935	152,081	126,234	284,725	244,486	205,323	180,982	147,795	168,174	134,728	106,722	84,995
買掛金	1,645	4,039	2,415	2,377	1,348	1,846	2,283	1,717	1,263	2,671	3,309	2,632	1,759	8,043	5,853	4,636	2,803	4,940	3,603	3,660	3,671	4,108	3,692	2,841	6,124	13,017	6,411	2,795	6,693	2,855	11,544	11,346	7,469	9,646
一年内返済予定の長期借入金	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,667	6,667	-	-	1,667	-	1,667	6,667	11,667	-	-
流動負債合計	6,149	8,348	9,567	6,865	7,016	9,239	12,413	21,337	17,679	21,297	19,529	14,979	15,332	22,570	23,516	19,808	23,200	28,063	28,624	27,369	27,623	29,880	31,508	27,593	38,927	38,424	30,778	23,551	28,375	28,394	36,681	37,303	24,521	28,392
長期借入金	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19,567	19,640	19,719	39,551	39,718	39,892	40,072	40,257	38,775	33,968	40,514	40,649	39,117	40,930	39,406	34,556	29,708	40,934	41,081
資本金及び資本剰余金	3	23	23	23	26	26	26	32	34	34	34	34	43	43	43	45	45	45	56	61	61	61	6	61	62	20	20	20	20	21	26	26	26	27
利益剰余金	-76,122	-90,291	-101,256	-112,771	-126,139	-139,964	-155,266	-169,729	-183,776	-199,513	-217,545	-234,006	-253,461	-273,254	-292,983	-310,209	-327,400	-346,900	-377,000	-391,200	-413,700	-439,800	-463,600	-488,700	-523,200	-553,500	-558,200	-582,000	-618,300	-658,400	-722,800	-726,500	-749,800	-756,200
株主資本	-68,413	90,781	80,602	70,136	91,081	78,592	65,324	104,499	108,712	94,837	78,586	64,018	111,915	94,574	79,184	76,543	62,406	45,940	90,553	149,880	129,977	106,060	85,218	62,742	31,019	129,171	127,736	106,753	73,239	36,302	16,662	15,057	-6,352	-11,123
有利子負債合計	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19,567	19,640	19,719	39,551	39,718	39,892	40,072	40,257	40,442	40,635	40,514	40,649	40,784	40,930	41,073	41,223	41,375	40,934	41,081
純有利子負債	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-105,395	-92,120	-76,500	-137,519	-185,510	-145,223	-108,598	-93,198	-72,905	-48,735	-207,053	-164,741	-128,105	-106,138	-74,232	-100,422	-69,048	-40,149	-19,313
DEレシオ（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25.56	31.47	42.92	43.68	26.5	30.69	37.78	47.24	64.46	131.0	31.36	31.82	38.2	55.89	113.14	247.41	274.79	-644.43	-369.33

Syros Pharmaceuticals, Inc.【SYRS】 業績推移・財務諸表

Syros Pharmaceuticals, Inc.【SYRS】業績推移・財務諸表